APA (7th ed.) Citation

CF, M., G, G., F, L., D, B., G, G., S, N., . . . A, B. (2020). Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities. The Journal of clinical investigation, 130(11), 6021. https://doi.org/10.1172/JCI138473

Chicago Style (17th ed.) Citation

CF, Magnani, et al. "Sleeping Beauty-engineered CAR T Cells Achieve Antileukemic Activity Without Severe Toxicities." The Journal of Clinical Investigation 130, no. 11 (2020): 6021. https://doi.org/10.1172/JCI138473.

MLA (9th ed.) Citation

CF, Magnani, et al. "Sleeping Beauty-engineered CAR T Cells Achieve Antileukemic Activity Without Severe Toxicities." The Journal of Clinical Investigation, vol. 130, no. 11, 2020, p. 6021, https://doi.org/10.1172/JCI138473.